Leerink Partners

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

Kinnate Biopharma develops precision oncology therapeutics to treat patients with genomically-defined cancers.

AlloVir focuses on the development of cell therapies and focuses on restoring natural immunity against the virus-associated diseases.

Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.

Precision BioSciences is a biotechnology company dedicated to improving life.

FogPharma is a biopharmaceutical firm that develops precision medicines for the vast majority of therapeutic targets.

Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.

Avrobio is a clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease.

Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.

Replimune Group develop the next generation of ‘oncolytic immunotherapies’ for the treatment of cancer.